Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study

NCT00501982 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Distress Syndrome, Newborn

Interventions

DRUG: Poractant alfa (Curosurf®)

Sponsor

Chiesi Farmaceutici S.p.A.